Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2018

01-01-2018 | Editorial

Vitamin D3 Versus Gliadin: A Battle to the Last Tight Junction

Authors: Alice Scricciolo, Leda Roncoroni, Vincenza Lombardo, Francesca Ferretti, Luisa Doneda, Luca Elli

Published in: Digestive Diseases and Sciences | Issue 1/2018

Login to get access

Excerpt

Celiac disease (CD), the most common chronic autoimmune enteropathy present in Western populations, is triggered by gluten ingestion in genetically susceptible individuals carrying the HLA DQ2 and/or DQ8 loci [1]. Gluten, a high molecular weight protein present in the endosperm of grass-related grains, including wheat, barley, and rye, is stored within seeds in order to ensure a stable nutrient supply supporting the germination and development of young plants. Gluten-containing cereals, the most important crop in the world, are used to make food products such as pasta, bread, other baked and pastry products. The viscoelastic and stabilizing properties of gluten have fostered its use as an additive in the baking industry; furthermore, it gives food greater palatability due to the creation of disulfide bonds that in combination with atmospheric oxygen and nitrogen alter the properties of the dough as a function of the sulfhydryl and disulfide content [1]. Gluten is a composite of two classes of protein, glutenins and prolamins (gliadin, secalin, and hordein), which can be further fractionated to produce peptides. Pepsin–trypsin-resistant gliadin (PT-G) is an undigested gliadin fragment that substantially contributes to the pathogenesis of CD by altering intercellular tight junctions (TJs) [2]. …
Literature
1.
go back to reference Elli L, Villalta D, Roncoroni L, et al. Nomenclature and diagnosis of gluten-related disorders: A position statement by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). Dig Liver Dis. 2017;49:138–146.CrossRefPubMed Elli L, Villalta D, Roncoroni L, et al. Nomenclature and diagnosis of gluten-related disorders: A position statement by the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). Dig Liver Dis. 2017;49:138–146.CrossRefPubMed
2.
go back to reference Elli L, Roncoroni L, Doneda L, et al. Imaging analysis of the gliadin direct effect on tight junctions in an in vitro three-dimensional Lovo cell line culture system. Toxicol In Vitro. 2011;25:45–50.CrossRefPubMed Elli L, Roncoroni L, Doneda L, et al. Imaging analysis of the gliadin direct effect on tight junctions in an in vitro three-dimensional Lovo cell line culture system. Toxicol In Vitro. 2011;25:45–50.CrossRefPubMed
5.
go back to reference Bjarnason I, Peters TJ, Veall N. Intestinal permeability defect in coeliac disease. Lancet. 1983;1:1284–1285.CrossRefPubMed Bjarnason I, Peters TJ, Veall N. Intestinal permeability defect in coeliac disease. Lancet. 1983;1:1284–1285.CrossRefPubMed
6.
go back to reference Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res. 1998;43:435–441.CrossRefPubMed Schulzke JD, Bentzel CJ, Schulzke I, Riecken EO, Fromm M. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res. 1998;43:435–441.CrossRefPubMed
7.
go back to reference Dolfini E, Roncoroni L, Elli L, et al. Cytoskeleton reorganization and ultrastructural damage induced by gliadin in a three-dimensional in vitro model. World J Gastroenterol. 2005;11:7597–7601.CrossRefPubMedPubMedCentral Dolfini E, Roncoroni L, Elli L, et al. Cytoskeleton reorganization and ultrastructural damage induced by gliadin in a three-dimensional in vitro model. World J Gastroenterol. 2005;11:7597–7601.CrossRefPubMedPubMedCentral
10.
go back to reference Equils O, Naiki Y, Shapiro AM, et al. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006;143:58–64.CrossRefPubMedPubMedCentral Equils O, Naiki Y, Shapiro AM, et al. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol. 2006;143:58–64.CrossRefPubMedPubMedCentral
11.
go back to reference Zonulin FA. Regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci. 2012;1258:25–33.CrossRef Zonulin FA. Regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci. 2012;1258:25–33.CrossRef
12.
go back to reference Bardella MT, Elli L, Ferretti F. Non celiac gluten sensitivity. Curr Gastroenterol Rep. 2016;18:63.CrossRefPubMed Bardella MT, Elli L, Ferretti F. Non celiac gluten sensitivity. Curr Gastroenterol Rep. 2016;18:63.CrossRefPubMed
13.
go back to reference Branchi F, Ferretti F, Norsa L, et al. Management of nonceliac gluten sensitivity by gastroenterology specialists: data from an Italian survey. Biomed Res Int. 2015;2015:530136.CrossRefPubMedPubMedCentral Branchi F, Ferretti F, Norsa L, et al. Management of nonceliac gluten sensitivity by gastroenterology specialists: data from an Italian survey. Biomed Res Int. 2015;2015:530136.CrossRefPubMedPubMedCentral
14.
go back to reference Camilleri M, Ford AC. Irritable bowel syndrome: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol. 2017;239:75–113.CrossRefPubMed Camilleri M, Ford AC. Irritable bowel syndrome: pathophysiology and current therapeutic approaches. Handb Exp Pharmacol. 2017;239:75–113.CrossRefPubMed
Metadata
Title
Vitamin D3 Versus Gliadin: A Battle to the Last Tight Junction
Authors
Alice Scricciolo
Leda Roncoroni
Vincenza Lombardo
Francesca Ferretti
Luisa Doneda
Luca Elli
Publication date
01-01-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4848-8

Other articles of this Issue 1/2018

Digestive Diseases and Sciences 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.